According to the Zhitong Finance App, Tengsheng Pharmaceutical-B (02137) issued an announcement to repurchase 101,000 shares at HK$85,000 on October 9, 2026; 5,875 shares were issued and distributed to employees of the Company due to the ownership of restricted share units granted under the 2023 share award scheme adopted by the Company on September 1, 2023.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.